Mustang Bio Company
Mustang Bio is a clinical-stage biopharmaceutical company .
.png)
Investors Number:
4
Industry:
CAR-T
Total Funding:
204300000
Last Funding Type:
Post-IPO Debt
Last Funding Date:
2022-03-08
Headquarters:
New York, New York, United States
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Founded Date:
2015-01-01